CompuGroup Medical SE & Co. KGaA (VIE:COP2)
Austria · Delayed Price · Currency is EUR 27.26
-0.02 (-0.07%)
At close: Mar 6, 2026
VIE:COP2 Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 28.24 | 34.6 | 45.92 | 73.41 | 68.97 |
Depreciation & Amortization | 72.19 | 73.73 | 71.04 | 78.93 | 75.83 |
Other Amortization | 34.5 | 36.05 | 33.3 | 33.05 | 28.73 |
Loss (Gain) From Sale of Assets | -0.17 | -1.16 | -1.04 | -0.16 | -1.69 |
Asset Writedown & Restructuring Costs | - | 1.87 | 11.45 | 0.34 | 6.15 |
Other Operating Activities | 0.37 | -32.26 | 27.94 | 2.63 | -23.74 |
Change in Accounts Receivable | -15.7 | 9.45 | 11.12 | -28.76 | -7.7 |
Change in Inventory | 0.07 | 4.21 | 10.58 | -8.79 | -2.28 |
Change in Accounts Payable | 0.42 | -0.55 | -21.08 | 15.57 | 23.91 |
Change in Unearned Revenue | 12.11 | -8.02 | -14.74 | -10.38 | 6.65 |
Change in Income Taxes | 16.97 | 9.04 | 10.84 | -17.82 | -14.01 |
Change in Other Net Operating Assets | -1.95 | 1.91 | -5.82 | 7.01 | 4.44 |
Operating Cash Flow | 147.03 | 128.88 | 179.53 | 145.03 | 165.27 |
Operating Cash Flow Growth | 14.08% | -28.21% | 23.79% | -12.25% | 10.23% |
Capital Expenditures | -21.23 | -24.81 | -18.97 | -25.85 | -27.05 |
Sale of Property, Plant & Equipment | 0.43 | 0.43 | 1.33 | 0.35 | 7.28 |
Cash Acquisitions | -6.88 | -47.58 | -50.24 | -64.77 | -94.16 |
Divestitures | - | 5.1 | - | 0.04 | 0.4 |
Sale (Purchase) of Intangibles | -38.53 | -38.11 | -48.88 | -50.56 | -44.39 |
Investment in Securities | - | -0.31 | -7.56 | -4.63 | -6.05 |
Investing Cash Flow | -66.22 | -105.28 | -124.33 | -145.41 | -163.98 |
Long-Term Debt Issued | 70 | 115 | 480 | 340 | 265.08 |
Long-Term Debt Repaid | -171.21 | -27.09 | -530.03 | -320.94 | -112.29 |
Net Debt Issued (Repaid) | -101.21 | 87.91 | -50.03 | 19.06 | 152.8 |
Repurchase of Common Stock | - | -14.64 | - | -9.11 | -96.1 |
Common Dividends Paid | -2.59 | -51.74 | -26.12 | -26.12 | -26.37 |
Other Financing Activities | -0.31 | -2.72 | -4.54 | -0.19 | -0.18 |
Financing Cash Flow | -104.1 | 18.81 | -80.69 | -16.36 | 30.15 |
Foreign Exchange Rate Adjustments | -0.83 | 0.45 | -0.57 | -0.08 | -0.02 |
Net Cash Flow | -24.13 | 42.87 | -26.06 | -16.83 | 31.43 |
Free Cash Flow | 125.79 | 104.08 | 160.56 | 119.18 | 138.23 |
Free Cash Flow Growth | 20.87% | -35.18% | 34.72% | -13.78% | 4.52% |
Free Cash Flow Margin | 10.09% | 8.77% | 13.08% | 10.14% | 13.01% |
Free Cash Flow Per Share | 2.41 | 1.97 | 3.06 | 2.28 | 2.61 |
Cash Interest Paid | 31.76 | 32.83 | 26.71 | 6.16 | 4.18 |
Cash Income Tax Paid | 16.27 | 40.51 | 26.59 | 39.03 | 49.28 |
Levered Free Cash Flow | 102.64 | 62.62 | 111.29 | 66.62 | 119.45 |
Unlevered Free Cash Flow | 120.87 | 83.47 | 129.84 | 72.32 | 122.83 |
Change in Working Capital | 11.9 | 16.04 | -9.09 | -43.17 | 11.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.